1.Fibrosing cholestatic hepatitis: a report of three cases.
Hun Kyung LEE ; Ghil Suk YOON ; Kwang Seon MIN ; Young Wha JUNG ; Yong Sang LEE ; Dong Jin SUH ; Eunsil YU
Journal of Korean Medical Science 2000;15(1):111-114
Fibrosing cholestatic hepatitis is an aggressive and usually fatal form of viral hepatitis in immunosuppressed patients. We report three cases of fibrosing cholestatic hepatitis in various clinical situations. Case 1 was a 50-year-old man who underwent a liver transplant for hepatitis B virus (HBV)-associated liver cirrhosis. Two and a half years after the transplant, he complained of fever and jaundice, and liver enzymes were slightly elevated. Serum HBsAg was positive. Case 2 was a 30-year-old man in an immunosuppressed state after chemotherapy for acute lymphoblastic leukemia. He was a HBV carrier. Liver enzymes and total bilirubin were markedly elevated. Case 3 was a 50-year-old man who underwent renal transplantation as a known HBV carrier. One year after the transplant, jaundice developed abruptly, but liver enzymes were not significantly elevated. Microscopically lobules were markedly disarrayed, showing ballooning degeneration of hepatocytes, prominent pericellular fibrosis, and marked canalicular or intracytoplasmic cholestasis. Portal inflammation was mild, but interphase activity was definite and cholangiolar proliferation was prominent. Hepatocytes were diffusely positive for HBsAg and HBcAg in various patterns. Patients died of liver failure within 1 to 3 months after liver biopsy in spite of anti-viral treatment.
Adult
;
Case Report
;
Cholestasis, Intrahepatic/virology
;
Cholestasis, Intrahepatic/immunology
;
Cholestasis, Intrahepatic/etiology*
;
Fibrosis
;
Hepatitis B/complications*
;
Human
;
Immunosuppression/adverse effects
;
Liver Transplantation
;
Male
;
Middle Age
2.Detection of CD4+CD25+ regulatory T cells in liver tissues of fibrosing cholestatic hepatitis after liver and kidney transplantation.
Zhen-wei LANG ; Bing SHEN ; Liang ZHANG ; Xiao-hong SHI ; Pei-qing MA ; Meng-dong LAN ; Zhi-chun MA ; Shu-hua JIN
Chinese Journal of Hepatology 2007;15(9):667-671
OBJECTIVESTo study the expression and distribution of CD4+CD25+ regulatory T cells (Treg) in liver tissues of patients with fibrosing cholestatic hepatitis (FCH) after liver and kidney transplantation and to investigate their roles in the pathogenesis of FCH.
METHODSLiver biopsy specimens from five patients with FCH were studied histopathologically. A specific marker for CD4+CD25+ regulatory T cells in those specimens was detected with anti-FOXP3 monoclonal antibody by immunohistochemistry. Apoptoses of hepatocytes were detected with in situ apoptosis detection TUNEL kit.
RESULTSFibrosis in portal and around portal areas, cholestasis in some of the hepatocytes and canaliculi, widespread ballooning and ground-glass appearance of liver cells, and positivity of HBsAg and HBcAg and Pre-S1 protein were seen in the livers of all cases. The positive signal of FOXP3 was located in the cytoplasm of lymphocytes and the positive cells were mainly aggregated in the portal areas as well as occasionally appearing in the hepatic sinusoids. There were many more apoptotic hepatocytes near the portal areas.
CONCLUSIONFibrosing cholestatic hepatitis has specific pathological characteristics which might be caused by high expressions of FOXP3 in liver tissues.
Adult ; Apoptosis ; Biopsy ; Cholestasis, Intrahepatic ; immunology ; metabolism ; pathology ; Forkhead Transcription Factors ; metabolism ; Humans ; Interleukin-2 Receptor alpha Subunit ; metabolism ; Kidney Transplantation ; Liver ; immunology ; metabolism ; pathology ; Liver Transplantation ; Male ; Middle Aged ; T-Lymphocytes, Regulatory ; immunology